Clinical Trials

Study Title:
Randomized Phase II/III Trial of Radiation with High Dose Cisplatin (100mg/m2) Every Three Weeks Versus Radiation with Low Dose Cisplatin (40mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

For more information about the trial above please contact the study team:

Principal Investigator, Bhishamjit Chera, at

Study Coordinator, Lydia Moats, at

Study Coordinator, Madison Avinger, at

Trial opened at the following institutions: Medical University of South Carolina